Evidence map›Paper›PMID 31827674›Full record

ArticleOxidative medicine and cellular longevity2019

Aloin Preconditioning Attenuates Hepatic Ischemia/Reperfusion Injury via Inhibiting TLR4/MyD88/NF-

Yichao Du, Baolin Qian, Lin Gao, Peng Tan, Hao Chen, Ankang Wang, Tianxiang Zheng, Shilin Pu, Xianming Xia, Wenguang Fu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Aloin Attenuates Oxidative Stress, Inflammation, and CClJournal of agricultural and food chemistry · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. The Dietary SupplementOxidative medicine and cellular longevity · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yichao DuAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.ORCID https://orcid.org/0000-0002-2222-4908
Baolin QianDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Lin GaoDepartment of Health Management, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Peng TanAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Hao ChenDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Ankang WangDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Tianxiang ZhengAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Shilin PuDepartment of Hepatobiliary Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Xianming XiaAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
Wenguang FuAcademician (Expert) Workstation of Sichuan Province, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.ORCID https://orcid.org/0000-0003-3672-9728
Affiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAloin exerts considerable protective effects in various disease models, and its effect on hepatic ischemia-reperfusion (HIR) injury remains unknown. This research is aimed at conducting an in-depth investigation of the antioxidant, anti-inflammatory, and antiapoptosis effects of aloin in HIR injury and explain the underlying molecular mechanisms.

methods

resultsWe found that 20 mg/kg was the optimum concentration of aloin for mitigating I/R-induced liver tissue damage, characterized by decreased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Aloin pretreatment substantially suppressed the generation of hepatic malondialdehyde (MDA), tumor necrosis factor alpha (TNF-

Indexed as

Alanine TransaminaseAnimalsApoptosisDisease Models, AnimalEmodinGlutathioneHepatocytesLipopolysaccharidesLiverMaleMalondialdehydeMiceMice, Inbred C57BLMyeloid Differentiation Factor 88NF-kappa BReactive Oxygen SpeciesAlanine TransaminasealloinEmodinGlutathioneLipopolysaccharidesMalondialdehydeMyd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BReactive Oxygen SpeciesToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID31827674
PMCPMC6886335
OpenAlexW2991600732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.